CN115247106A - Endoscope multienzyme cleaning composition and application thereof - Google Patents
Endoscope multienzyme cleaning composition and application thereof Download PDFInfo
- Publication number
- CN115247106A CN115247106A CN202210045248.4A CN202210045248A CN115247106A CN 115247106 A CN115247106 A CN 115247106A CN 202210045248 A CN202210045248 A CN 202210045248A CN 115247106 A CN115247106 A CN 115247106A
- Authority
- CN
- China
- Prior art keywords
- parts
- endoscope
- diethanolamine
- cleaning
- cleaning solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004140 cleaning Methods 0.000 title claims abstract description 107
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 41
- 229940088598 enzyme Drugs 0.000 claims abstract description 39
- 102000016943 Muramidase Human genes 0.000 claims abstract description 24
- 108010014251 Muramidase Proteins 0.000 claims abstract description 24
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 24
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 24
- 229960000274 lysozyme Drugs 0.000 claims abstract description 19
- 239000004325 lysozyme Substances 0.000 claims abstract description 19
- 229940051921 muramidase Drugs 0.000 claims abstract description 5
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 34
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 26
- 229940043237 diethanolamine Drugs 0.000 claims description 21
- 239000004382 Amylase Substances 0.000 claims description 17
- 102000013142 Amylases Human genes 0.000 claims description 17
- 108010065511 Amylases Proteins 0.000 claims description 17
- 108091005658 Basic proteases Proteins 0.000 claims description 17
- 108010059892 Cellulase Proteins 0.000 claims description 17
- 102000004882 Lipase Human genes 0.000 claims description 17
- 239000004367 Lipase Substances 0.000 claims description 17
- 108090001060 Lipase Proteins 0.000 claims description 17
- 102000006382 Ribonucleases Human genes 0.000 claims description 17
- 108010083644 Ribonucleases Proteins 0.000 claims description 17
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 17
- 235000019418 amylase Nutrition 0.000 claims description 17
- 229910021538 borax Inorganic materials 0.000 claims description 17
- 229940106157 cellulase Drugs 0.000 claims description 17
- 235000019421 lipase Nutrition 0.000 claims description 17
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 claims description 17
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 17
- 235000011152 sodium sulphate Nutrition 0.000 claims description 17
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 17
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 claims description 17
- 238000005406 washing Methods 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 5
- 229960004599 sodium borate Drugs 0.000 claims description 2
- 229960003010 sodium sulfate Drugs 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 14
- 108090000623 proteins and genes Proteins 0.000 abstract description 9
- 102000004169 proteins and genes Human genes 0.000 abstract description 8
- 241000700605 Viruses Species 0.000 abstract description 6
- 239000012459 cleaning agent Substances 0.000 abstract description 6
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 230000001079 digestive effect Effects 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 230000002378 acidificating effect Effects 0.000 abstract description 2
- 238000001839 endoscopy Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 230000003321 amplification Effects 0.000 description 21
- 238000003199 nucleic acid amplification method Methods 0.000 description 21
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 12
- 239000002299 complementary DNA Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 238000001514 detection method Methods 0.000 description 10
- 238000002791 soaking Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000645 desinfectant Substances 0.000 description 9
- 239000006210 lotion Substances 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000000137 annealing Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 238000010839 reverse transcription Methods 0.000 description 6
- 238000003757 reverse transcription PCR Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000007865 diluting Methods 0.000 description 5
- 206010011409 Cross infection Diseases 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 241000700721 Hepatitis B virus Species 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000003344 environmental pollutant Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 231100000719 pollutant Toxicity 0.000 description 3
- 238000012257 pre-denaturation Methods 0.000 description 3
- 238000005201 scrubbing Methods 0.000 description 3
- 208000006379 syphilis Diseases 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000711549 Hepacivirus C Species 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- 206010029803 Nosocomial infection Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010064091 Iatrogenic infection Diseases 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000531 effect on virus Effects 0.000 description 1
- 238000001861 endoscopic biopsy Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- -1 mucus Substances 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000002957 persistent organic pollutant Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38618—Protease or amylase in liquid compositions only
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/12—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor with cooling or rinsing arrangements
- A61B1/121—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor with cooling or rinsing arrangements provided with means for cleaning post-use
- A61B1/122—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor with cooling or rinsing arrangements provided with means for cleaning post-use using cleaning tools, e.g. brushes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/70—Cleaning devices specially adapted for surgical instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B3/00—Cleaning by methods involving the use or presence of liquid or steam
- B08B3/04—Cleaning involving contact with liquid
- B08B3/08—Cleaning involving contact with liquid the liquid having chemical or dissolving effect
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B9/00—Cleaning hollow articles by methods or apparatus specially adapted thereto
- B08B9/02—Cleaning pipes or tubes or systems of pipes or tubes
- B08B9/023—Cleaning the external surface
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B9/00—Cleaning hollow articles by methods or apparatus specially adapted thereto
- B08B9/02—Cleaning pipes or tubes or systems of pipes or tubes
- B08B9/027—Cleaning the internal surfaces; Removal of blockages
- B08B9/032—Cleaning the internal surfaces; Removal of blockages by the mechanical action of a moving fluid, e.g. by flushing
- B08B9/0321—Cleaning the internal surfaces; Removal of blockages by the mechanical action of a moving fluid, e.g. by flushing using pressurised, pulsating or purging fluid
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38636—Preparations containing enzymes, e.g. protease or amylase containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38645—Preparations containing enzymes, e.g. protease or amylase containing cellulase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/02—Inorganic compounds
- C11D7/04—Water-soluble compounds
- C11D7/10—Salts
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/263—Ethers
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/32—Organic compounds containing nitrogen
- C11D7/3218—Alkanolamines or alkanolimines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/17—Combination with washing or cleaning means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
- C11D2111/10—Objects to be cleaned
- C11D2111/14—Hard surfaces
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
- C11D2111/40—Specific cleaning or washing processes
- C11D2111/44—Multi-step processes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mechanical Engineering (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Radiology & Medical Imaging (AREA)
- Inorganic Chemistry (AREA)
- Detergent Compositions (AREA)
Abstract
The invention provides a multi-enzyme composition for cleaning an endoscope and a method for cleaning the endoscope by adopting the multi-enzyme composition. The invention provides the multienzyme composition comprising lysozyme and muramidase, the step-by-step cleaning and the step-by-step cleaning operation under the alkaline and weakly acidic conditions respectively, so that the protein residue on the surface of the endoscope and the pollution of various viruses can be effectively removed, and the cleaning agent has a good cleaning effect on the biofilm pollution easily formed on the surface of the endoscope. Can obviously improve the cleaning quality of the digestive endoscopy, ensures the disinfection and sterilization effect and avoids the infection of hospitals.
Description
Technical Field
The invention belongs to the technical field of medical cleaning agents, and particularly relates to an endoscope multienzyme cleaning composition and application thereof.
Background
In recent years, with the gradual increase of precise and complex medical instruments, medical biomaterials such as various catheters, pacemakers, artificial valves, implants, dialysis techniques, endoscopes and the like are also widely used.
The cleaning and disinfection work of the endoscope is an important measure for preventing hospital infection, and the cleaning effect of the endoscope directly influences the disinfection effect. The technical operating specification of endoscope cleaning and disinfection issued by the ministry of health in 2004 defines that one person needs to carry out one lens one enzyme when a multienzyme lotion is used in endoscope cleaning, the enzyme lotion can effectively remove proteoglycan, fat and carbohydrate adhered to the surface of the endoscope, so that the quantity of organic matters and microorganisms remained on the surface of the endoscope is minimized, and whether the endoscope is thoroughly and reliably cleaned and disinfected directly relates to the safety of patients.
As the endoscope has a complex and fine structure and is fast in clinical turnover, the disinfection and cleaning of the endoscope are always a big problem in hospitals for many years. In the past, the endoscope is cleaned only by using clean water, so that the dirt such as body fluid, mucus, blood and the like adhered to the surface of the endoscope is difficult to be dissolved completely, and the dirt is solidified into crystals and is gathered on the surface of the gastroscope and in each lumen due to the contact with acetaldehyde compound glutaraldehyde, so that the disinfection effect is not ideal. The investigation shows that the main microorganisms polluted by the endoscope are staphylococcus aureus, pseudomonas aeruginosa, escherichia coli, hepatitis b virus, mycobacterium and the like. A large number of researches prove that the enzyme cleaning agent can decompose organic matters and proteins of a human body, reduce the microbial load on the surface of an object by 3-5 logarithmic levels, effectively digest protein components in bacterial endotoxin, make the bacterial endotoxin lose active components, and has the effect of removing pyrogen. Therefore, the enzyme cleaning agent is selected as the precondition for ensuring thorough cleaning.
The enzyme lotion can effectively remove proteoglycan, fat and carbohydrate adhered to the surface of the endoscope, so that the quantity of organic matters and microorganisms remained on the surface of the endoscope is reduced to the minimum, and whether the endoscope is thoroughly and reliably cleaned and disinfected directly relates to the safety of patients.
Infections centered on biomaterials due to the adhesion of bacteria to the surface of biomaterials forming biofilms) are becoming increasingly serious. The existence of the biological membrane enables bacteria to resist the cleaning and disinfection effects, causes the failure of cleaning and disinfection of biological materials and becomes a potential factor of nosocomial infection
The biofilm is a protective growth mode of bacteria, and due to the existence of the biofilm, the drug resistance of bacteria in the biofilm is more than 1000 times higher than that of bacteria in a planktonic state, so that clinically serious nosocomial infection can be caused by the formation of the bacterial biofilm, and data show that clinical bacterial infection caused by the biofilm accounts for more than 60% of the infection rate. In clinical reuse cavity type instruments (such as endoscopes), due to the characteristics of the instruments, deposits and minerals which are difficult to clean can be generated and adhered to and accumulated on the surfaces of the instruments during use, and in actual use, the instruments are often contacted with organic pollutants such as mucus, saliva, blood and the like, and the pollutants can easily cause the formation of bacterial biofilms on the surfaces of the instruments and in the cavities of the instruments. Once the biofilm is formed, the bacteria in the inner layer are protected by outer secretion polysaccharide and protein components, and cannot be sufficiently exposed to a disinfectant or a sterilizing agent, so that the disinfection or sterilization fails, and hospital infection is caused.
Bacterial biofilms are aggregates of microbial cells bound to surfaces, typically encased in an extracellular polymeric polysaccharide matrix and forming a membranous-like structure. Biofilms can form on a variety of surfaces, including living tissue, indwelling medical devices, water body lines for various uses, or natural water systems, and bacterial biofilms continue to grow until mature. The biofilm formation process comprises 5 stages, namely reversible adsorption of bacteria, irreversible attachment of EPS matrix, proliferation and division of bacteria, generation of extracellular polymers and initial formation of a biofilm, and attachment of other microorganisms on the biofilm. With the maturation of the biological membrane, the resistance of the biological membrane to antibacterial drugs and bactericides is enhanced, and if the biological membrane in the multiplexing medical instrument is not removed, the sterilization quality of the biological membrane cannot be guaranteed. According to the journal of the science of the united states, mucus on walls, plaque on teeth and films formed on various surfaces of medical instruments or hospital articles in the shower are bacterial biofilms which persist after scrubbing and even antibacterial treatment.
Digestive endoscopy is an important tool for diagnosing and treating digestive tract diseases, and is applied more and more widely in clinic. As an invasive instrument, a digestive endoscope is easily polluted by tissues, body fluids, blood and the like of a patient, and is one of potential risk factors of iatrogenic infection due to the complex structure, special material and difficult cleaning and disinfection. At present, the biological film is generally considered to be an important factor causing endoscope infection, and the removal effect of the biological film directly influences the disinfection quality of the endoscope. Biofilm (BF) protects bacteria from the environment and increases bacterial resistance to disinfectants, the formation of which can significantly reduce the effectiveness of disinfectants. Bacterial biofilms have been found to be ubiquitous in disinfected endoscopes, which play an important role in endoscope-related infections. The cleaning effect of the biological film can guide the correct selection and use of the cleaning agent in the clinical endoscope reprocessing.
The existing cleaning agent has the defects of low cleaning efficiency, incomplete cleaning of internal dirt and the like generally existing in medical instruments such as endoscopes and lumen medical instruments which are difficult to clean, and particularly has limited cleaning effect on virus pollution and biomembrane pollution in the using process of the endoscopes. The endoscope cleaning composition or the cleaning liquid provided by the invention can be used for efficiently cleaning the endoscope, effectively removing the virus pollution in the using process of the endoscope, has a good cleaning effect on the formation of an endoscope biomembrane, and is worthy of popularization and application in clinical application.
Disclosure of Invention
The invention aims to provide an improved endoscope cleaning composition or cleaning solution, aiming at the problems that the cleaning solution in the prior art has low cleaning efficiency, can not completely remove the dirt in the endoscope, lumen medical instruments and the like, and particularly has limited effect on removing virus pollution and biomembrane pollution in the using process of the endoscope.
In order to solve the technical problems, the invention adopts the following technical scheme.
The invention discloses a multi-enzyme composition for cleaning an endoscope, which comprises a composition A and a composition B, wherein the composition A comprises the following components in parts by weight: alkaline protease, lipase, amylase, cellulase, ribonuclease, polyvinyl methyl ether, diethanolamine; the composition B comprises: lysozyme, muramidase, sodium borate, diethanolamine and sodium sulfate.
Preferably, the composition a comprises, by mass: 1-20 parts of alkaline protease, 0.5-10 parts of lipase, 0.5-10 parts of amylase, 0.5-10 parts of cellulase, 0.01-0.5 part of ribonuclease, 0.1-2 parts of polyvinyl methyl ether and 0.1-2 parts of diethanolamine; the composition B comprises the following components in parts by mass: 1-5 parts of lysozyme, 1-5 parts of lywallzyme, 0.1-2 parts of sodium borate, 0.1-2 parts of diethanolamine and 0.1-2 parts of sodium sulfate.
Preferably, the composition a comprises, by mass: 5 parts of alkaline protease, 3 parts of lipase, 2 parts of amylase, 2 parts of cellulase, 0.05 part of ribonuclease, 0.5 part of polyvinyl methyl ether, 0.5 part of diethanolamine and the composition B, which are calculated according to the parts by mass, comprise the following components: 3 parts of lysozyme, 3 parts of lywallzyme, 0.5 part of sodium borate, 0.5 part of diethanolamine and 0.5 part of sodium sulfate.
The invention discloses a multienzyme cleaning solution for cleaning an endoscope, which comprises a multienzyme cleaning solution A and a multienzyme cleaning solution B, wherein the multienzyme cleaning solution A is prepared by dissolving alkaline protease, lipase, amylase, cellulase, ribonuclease, polyvinyl methyl ether and diethanol amine in normal saline, and the pH value is adjusted to be 7-9; the multienzyme cleaning solution B is prepared by dissolving lysozyme, lywallzyme, sodium borate, diethanolamine and sodium sulfate in normal saline, and the pH value is adjusted to 5-7.
Preferably, the pH is adjusted with sodium hydroxide or hydrochloric acid, respectively.
Preferably, the endoscope is cleaned by the multienzyme cleaning solution A under the alkaline condition so as to remove pollutants such as protein, nucleic acid and the like attached to the surface of the endoscope.
Preferably, the endoscope is cleaned by the multienzyme cleaning solution B under an acidic condition so as to remove pollutants such as bacterial biofilms and the like attached to the surface of the endoscope.
Preferably, the multienzyme cleaning solution A is prepared from the following components in parts by mass: 1-20% of alkaline protease, 0.5-10% of lipase, 0.5-10% of amylase, 0.5-10% of cellulase, 0.01-0.5% of ribonuclease, 0.1-2% of polyvinyl methyl ether, 0.1-2% of diethanolamine, and the balance of normal saline; the multienzyme cleaning solution B is prepared from the following components in parts by mass: 1-5% of lysozyme, 1-5% of lywallzyme, 0.1-2% of sodium borate, 0.1-2% of diethanolamine, 0.1-2% of sodium sulfate and the balance of physiological saline.
Preferably, the multienzyme cleaning solution A is prepared from the following components in parts by mass: 5% of alkaline protease, 3% of lipase, 2% of amylase, 2% of cellulase, 0.05% of ribonuclease, 0.5% of polyvinyl methyl ether, 0.5% of diethanolamine and the balance of normal saline, and the pH value is adjusted to 7.5; the multienzyme cleaning solution B is prepared from the following components in parts by mass: 3% lysozyme, 3% lywallzyme, 0.5% sodium borate, 0.5% diethanolamine, 0.5% sodium sulfate, and the balance normal saline, and the pH value is adjusted to 6.5.
The invention discloses a preparation method of a multienzyme cleaning solution for cleaning an endoscope, which comprises the following steps: respectively weighing alkaline protease, lipase, amylase, cellulase, ribonuclease, polyvinyl methyl ether and diethanolamine, dissolving in normal saline, adjusting pH value to 7-9, and using as multienzyme cleaning solution A; weighing lysozyme, lywallzyme, sodium borate, diethanolamine and sodium sulfate respectively, dissolving in normal saline, adjusting pH to 5-7, and using as multienzyme cleaning solution B.
Preferably, 1-20g of alkaline protease, 0.5-10g of lipase, 0.5-10g of amylase, 0.5-10g of cellulase, 0.01-0.5g of ribonuclease, 0.1-2g of polyvinyl methyl ether and 0.1-2g of diethanolamine are respectively weighed, the volume is fixed to 100mL by using normal saline, the pH value is adjusted to 7-9, and the solution is used as a multienzyme cleaning solution A; respectively weighing 1-5g of lysozyme, 1-5g of muramidase, 0.1-2g of sodium borate, 0.1-2g of diethanolamine and 0.1-2g of sodium sulfate, diluting to 100mL by using normal saline, and adjusting the pH value to 5-7 to obtain a multienzyme cleaning solution B. Preferably, 5g of alkaline protease, 3g of lipase, 2g of amylase, 2g of cellulase, 0.05g of ribonuclease, 0.5g of polyvinyl methyl ether and 0.5g of diethanolamine are weighed, the volume is adjusted to 100mL by using normal saline, and the pH value is adjusted to 7-9 to be used as a multienzyme cleaning solution A; 3g of lysozyme, 3g of lywallzyme, 0.5g of sodium borate, 0.5g of diethanolamine and 0.5g of sodium sulfate are respectively weighed, the volume is determined to be 100mL by using normal saline, and the pH value is adjusted to be 5-7 to be used as multienzyme cleaning solution B.
The invention discloses a kit, which comprises the multi-enzyme composition or the multi-enzyme cleaning solution.
The invention discloses application of the multienzyme composition or the multienzyme cleaning solution or the kit in cleaning a medical endoscope.
The invention discloses a multienzyme cleaning method of an endoscope, which comprises the following steps: (1) Taking the endoscope used in case examination, repeatedly wiping off dirt on the surface by using wet gauze, placing the endoscope in a 1 st groove, cleaning the endoscope by using flowing water, and repeatedly scrubbing the endoscope by using the gauze; (2) Placing the composition A or the multi-enzyme lotion A in a No. 2 groove, diluting with normal saline, wherein the water temperature is 30-38 ℃, placing the endoscope treated in the step (1) in the No. 2 groove, soaking for 10-25 minutes, sucking the enzyme liquid by using an injector during the soaking, repeatedly cleaning the lumen of the endoscope, wiping the surface of the endoscope with the enzyme liquid, and then washing with flowing water; (3) Placing the composition B or the multi-enzyme washing liquid B in a3 rd groove, diluting with normal saline, wherein the water temperature is 30-38 ℃, placing the endoscope washed in the step (2) in the 3 rd groove, soaking for 10-25 minutes, sucking the enzyme liquid by using an injector to repeatedly wash the lumen of the endoscope, wiping the surface of the endoscope with the enzyme liquid, and then washing with flowing water; (4) Preparing 2% glutaraldehyde as a disinfectant in the 4 th tank, placing the endoscope subjected to washing treatment in the step (3) in the 4 th tank, soaking for 15-25 minutes, sucking the disinfectant by using an injector to repeatedly clean the lumen of the endoscope, wiping the surface of the endoscope with the disinfectant, and washing with flowing water; (5) And (5) placing the endoscope washed in the step (4) in a 5 th groove, continuously washing the surface and the lumen of the endoscope by flowing water, wiping by a disinfection towel, and then blowing for later use.
Preferably, the pH is adjusted with sodium hydroxide or hydrochloric acid, respectively.
Preferably, the water temperature in the step (2) is 37 ℃, and the soaking time is 15 minutes.
Preferably, the water temperature in the step (3) is 37 ℃ and the soaking time is 15 minutes.
Preferably, the soaking time in step (4) is 20 minutes.
The invention provides the multienzyme composition comprising lysozyme and muramidase and the step-by-step cleaning, can effectively remove protein residues on the surface of the endoscope and the pollution of various viruses, and particularly has good effect of removing the biofilm pollution easily formed on the surface of the endoscope.
Drawings
FIG. 1 is a statistical graph showing the detection of protein residues after endoscope washing.
FIG. 2 shows the electrophoresis chart of the residual detection RT-PCR of hepatitis B virus after endoscope cleaning. Wherein, lane 1 is marker, lane 2 is positive control, lane 3-6 is amplification result of control group, and lane 7-11 is amplification result of the method of the invention.
FIG. 3 shows the electrophoresis chart of the hepatitis C virus residual detection RT-PCR after endoscope cleaning. Wherein, lane 1 is marker, lane 2 is positive control, lane 3-6 is amplification result of control group, and lane 7-11 is amplification result of the method of the invention.
FIG. 4 shows the RT-PCR electrophoretogram for detecting syphilis virus residues after endoscope cleaning. Wherein, lane 1 is marker, lane 2 is positive control, lane 3-6 is amplification result of control group, and lane 7-11 is amplification result of the method of the invention.
Detailed Description
The following detailed description of embodiments of the invention refers to the accompanying drawings. It should be understood that the detailed description and specific examples, while indicating the present invention, are given by way of illustration and explanation only, not limitation.
EXAMPLE 1 preparation of Multi-enzyme Wash
1) Preparation of the multiple enzyme composition A. Respectively weighing 5g of alkaline protease, 3g of lipase, 2g of amylase, 2g of cellulase, 0.05g of ribonuclease, 0.5g of polyvinyl methyl ether and 0.5g of diethanolamine, and uniformly mixing.
Preparation of multiple enzyme Wash A. The prepared multienzyme composition A is dissolved in normal saline, the volume is adjusted to 100mL, and the pH value is adjusted to 7.6 by sodium hydroxide.
2) Preparation of the multienzyme composition B. 3g of lysozyme, 3g of lywallzyme, 0.5g of sodium borate, 0.5g of diethanolamine and 0.5g of sodium sulfate are respectively weighed and mixed uniformly.
And (3) preparing a multi-enzyme lotion B. Dissolving the prepared multienzyme composition B in normal saline, fixing the volume to 100mL, and adjusting the pH value to 6.3 by using hydrochloric acid.
EXAMPLE 2 cleaning operation of endoscope
1) Cleaning endoscope operation using the cleaning composition of the present invention
(1) Taking an endoscope used in case examination, repeatedly wiping off dirt on the surface by using wet gauze, cleaning the endoscope by using flowing water in a 1 st groove, and repeatedly scrubbing the endoscope by using the gauze;
(2) Placing 20mL of the multi-enzyme washing solution A in the example 1 in A2 nd tank, diluting with normal saline to a constant volume of 1000mL, wherein the water temperature is 38 ℃, placing the endoscope treated in the step (1) in the 2 nd tank, soaking for about 20 minutes, sucking the enzyme solution by using a syringe to repeatedly clean the lumen of the endoscope, wiping the surface of the endoscope with the enzyme solution, and then washing with flowing water;
(3) Placing 20mL of the multi-enzyme washing solution B in the embodiment 1 in a3 rd groove, diluting with normal saline to a constant volume of 1000mL, wherein the water temperature is 38 ℃, placing the endoscope washed in the step (2) in the 3 rd groove, soaking for about 22 minutes, sucking the enzyme solution by using an injector to repeatedly wash the lumen of the endoscope, wiping the surface of the endoscope with the enzyme solution, and then washing with flowing water;
(4) Preparing 2% glutaraldehyde as a disinfectant in the 4 th tank, placing the endoscope subjected to washing treatment in the step (3) in the 4 th tank, soaking for about 18 minutes, sucking the disinfectant by using an injector to repeatedly clean the lumen of the endoscope, wiping the surface of the endoscope with the disinfectant, and washing with flowing water;
(5) And (5) placing the endoscope washed in the step (4) in a 5 th groove, continuously washing the surface and the lumen of the endoscope by flowing water, wiping by a disinfection towel, and then blowing for later use.
2) Control group cleaning endoscope operation (with quadruple ferment cleanser)
Referring to the endoscope cleaning operation flow of the cleaning composition of the present invention in 1), the multi-enzyme lotion a in step (2) and the multi-enzyme lotion B in step (3) were respectively replaced with a quadruple enzyme (Rapidmult i-enzymeklener) cleaner and diluted by the corresponding times according to the manufacturer's recommended ratio.
Example 3 detection of protein residues after endoscope cleaning
50 sets of postoperative endoscopes are selected respectively and cleaned by the method of the embodiment 1 and the contrast method. For the cleaned endoscope, a residual protein detection bar Pro-tect test is adopted, and according to the evaluation of the change of the detection bar, green is negative (-), light grey (light purple) is weak positive (+), grey (purple) is positive (+ +), dark grey (brown purple) is strong positive (+ +), and the endoscope is judged to be qualified if being negative. The yield results obtained with the method of the invention and the control method are referenced to fig. 1 (P < 0.05). The two methods for cleaning the endoscope have high protein clearance rate, and the cleaning method has a high protein removal effect.
Example 4 ATP fluorescence detection after endoscope cleaning
50 sets of postoperative endoscopes are selected respectively and cleaned by the method of the embodiment 1 and the contrast method. For the cleaned endoscope, a swab head brush is cut off according to the instructions and put into an Ultrasnap ATP fluorescence sampling rod, and an ATP detection instrument is used for reading. According to the product description, the product is judged to be unqualified (positive) when the Relative Light Unit (RLU) value is more than or equal to 150. The results of the measurements are shown in Table 1 below.
Table 1: ATP fluorescence detection for endoscope cleaning
Number of endoscopes to be cleaned | Number of endoscopes qualified in ATP detection | Percent of pass | |
The method of the invention | 50 | 50 | 100% |
Control | 50 | 48 | 96% |
EXAMPLE 5 detection of hepatitis B Virus residue after endoscopic cleaning
10 sets of endoscopes used after operation of patients with positive hepatitis B are selected respectively and cleaned by the method of the embodiment 1 and the contrast method. For the cleaned endoscope, the liquid in the 5 th tank is taken as the object of reverse transcription amplification.
And taking 10 muL of the cleaning solution in the step, and adding 2 muL OLigo d (T), 4 muL of 5 xM-MLV Buffer and dNTP (10 mmol/muL) into the solution. 4 muL, 0.5 muL of an RNA inhibitor, and 0.5 muL of M-MLV. Then putting the cDNA into a water bath at 42 ℃ for incubation for 1h 20min, putting the cDNA into a water bath kettle at 72 ℃ again for 10min, and then taking the cDNA out, namely carrying out reverse transcription to obtain the cDNA.
Wherein, 5 sets of cleaning solution are randomly selected from 10 sets to be respectively reverse-transcribed, and 4 sets of cleaning solution are randomly selected from 10 sets to be respectively reverse-transcribed.
Designing a primer according to the sequence of the hepatitis B core region:
wherein the sequence of the upstream primer is as follows: 5 'ggagctcactg tggagtttactict 3';
the sequence of the downstream primer is as follows: 5 'gattccga gattgagatc t3';
and (3) performing amplification by using an RT-PCR method. The reaction conditions are as follows:
pre-denaturation at 95 ℃ for 5 min, annealing at 94 ℃ for 30 sec, annealing at 56 ℃ for 35 sec, extension at 72 ℃ for 40 sec, 40 cycles, and final extension at 72 ℃ for 10 min. The amplification results are shown in FIG. 2. Wherein: lane 1 is marker, lane 2 is positive control (concentration is 50 ng/L), lane 3-6 is control amplification result, and lane 7-11 is amplification result by the method of the present invention.
Example 6 hepatitis C Virus residual detection after endoscope cleaning
10 sets of endoscopes used after operation of patients with positive hepatitis C are selected respectively and cleaned by the method of the embodiment 1 and the control method. For the cleaned endoscope, the liquid in the 5 th tank is taken as the object of reverse transcription amplification.
Taking 10 muL of the cleaning solution in the step, and adding 2 muL OLigo d (T), 4 muL of 5 XM-MLV Buffer and dNTP (10 mmol/muL) into the solution. 4 muL, 0.5 muL of an RNA inhibitor, and 0.5 muL of M-MLV. Then putting the cDNA into a water bath at 42 ℃ for incubation for 1h 20min, putting the cDNA into a water bath kettle at 72 ℃ again for 10min, and then taking the cDNA out, namely carrying out reverse transcription to obtain the cDNA.
Wherein, 5 sets of cleaning solution are randomly selected from 10 sets to be respectively reverse-transcribed, and 4 sets of cleaning solution are randomly selected from 10 sets to be respectively reverse-transcribed.
Designing a primer according to the sequence of hepatitis C:
wherein the sequence of the upstream primer is as follows: 5 'tcccctgtgtgtga ggaacta3';
the sequence of the downstream primer is as follows: 5 'gtttagggattcgtgctcca 3';
and (3) performing amplification by using an RT-PCR method. The reaction conditions are as follows:
pre-denaturation at 95 ℃ for 5 min, annealing at 94 ℃ for 30 sec, annealing at 58 ℃ for 30 sec, extension at 72 ℃ for 35 sec, 40 cycles, and final extension at 72 ℃ for 10 min. The amplification results are shown in FIG. 3. Wherein: lane 1 is marker, lane 2 is positive control (concentration is 50 ng/L), lane 3-6 is control amplification result, and lane 7-11 is amplification result by the method of the present invention.
Example 7 detection of residual syphilis Virus after endoscopic cleaning
10 sets of endoscopes used by patients with syphilis as positive after operation are selected respectively, and the endoscopes are cleaned by the method of the embodiment 1 and the control method. For the cleaned endoscopes, the liquid in the 5 th tank is taken as the object of reverse transcription amplification.
And taking 10 muL of the cleaning solution in the step, and adding 2 muL OLigo d (T), 4 muL of 5 xM-MLV Buffer and dNTP (10 mmol/muL) into the solution. 4 muL, 0.5 muL of an RNA inhibitor, and 0.5 muL of M-MLV. Then putting the cDNA into a water bath at 42 ℃ for incubation for 1h 20min, putting the cDNA into a water bath kettle at 72 ℃ again for 10min, and then taking the cDNA out, namely carrying out reverse transcription to obtain the cDNA.
Wherein, 5 sets of cleaning solution are randomly selected from 10 sets to be respectively reverse-transcribed, and 4 sets of cleaning solution are randomly selected from 10 sets to be respectively reverse-transcribed.
Designing a primer according to the bmp gene of the treponema pallidum:
wherein the sequence of the upstream primer is as follows: 5 'cagat acatagttcc cg';
the sequence of the downstream primer is as follows: 5 'gtcgagcaccttgccgagc';
and (3) performing amplification by using an RT-PCR method. The reaction conditions are as follows:
pre-denaturation at 95 ℃ for 5 min, annealing at 94 ℃ for 30 sec, annealing at 55 ℃ for 55 sec, extension at 72 ℃ for 55 sec, 40 cycles, and final extension at 72 ℃ for 10 min. The amplification results are shown in FIG. 4. Wherein: lane 1 is marker, lane 2 is positive control (concentration is 50 ng/L), lane 3-6 is control amplification result, and lane 7-11 is amplification result by the method of the present invention.
EXAMPLE 8 establishment of model of Artificial biofilm
1) Inoculating Escherichia coli strain in sterile Muller-Hinton broth culture medium to obtain pure strain liquid, and adjusting bacteria concentration to 10 6 CFU/mL is ready for use.
2) Adding the prepared bacterial suspension into a container200ml TSB Erlenmeyer flask, make its bacterial liquid concentration 10 2 CFU/mL is ready for use. The flask was stoppered with a stopple with vent holes (filter layer 0.22 mm), extended through the vent holes to the bottom of the flask, and a fresh endoscopic biopsy tube 40 cm, 2mm in diameter, a reservoir bag and tubing, an infusion pump were connected to the bacterial suspension to form a closed loop culture system (maintain at 37 ℃,4 h/d was circulated at 12 ml/min with a peristaltic pump, tryptone soy broth medium (TSB) was changed daily, 5 d was continuously cultured, 6 d was used to flush the lumen with 500 ml sterile saline at a flow rate of 10 ml/min, and a 1.8cm sample was taken per 10cm length for use.
Example 9 cleaning of endoscopic Artificial biofilm model and viable count of biofilm
Each 5 sections of the prepared endoscope model tube were cleaned by the method of example 1 and the control method. And sampling the cleaned sample tube to be detected according to GB 15982. "take 50ml sterile sample solution (phosphate buffer solution containing corresponding neutralizer) with sterile syringe, inject from the inlet of the test tube" wash, then collect with 100ml sterile blue cap reagent bottle full volume at the outlet of biopsy tube. The eluate was mixed well, 1.0ml was inoculated into a dish, and the number of colonies (CFU/piece) was counted. The counting results are shown in tables 2 and 3 below.
Table 2: the cleaning method of the invention counts the number of viable bacteria in the biological membrane
|
|
|
|
|
|
Count of bacterial colony | 12 CFU/ |
8 CFU/piece | 15 CFU/piece | 14 CFU/ |
7 CFU/piece |
From the counting results in table 2, the colony count of the endoscope after cleaning is lower than 20 CFU/piece by the cleaning method of the present invention.
Table 3: comparison group cleaning method biological membrane viable count counting result
|
|
|
|
|
|
Count of bacterial colony | 117 CFU/piece | 84 CFU/piece | 53 CFU/piece | 71 CFU/piece | 62 CFU/piece |
The colony count of the cleaned endoscope is higher by adopting the method of the control group, which indicates that the method of the control group has poor effect on removing the endoscope biomembrane.
The present invention is illustrated by the above examples, but the present invention is not limited to the above process steps, i.e., it is not meant to imply that the present invention must rely on the above process steps to be practiced. It will be apparent to those skilled in the art that any modification of the present invention, equivalent substitutions of selected materials and additions of auxiliary components, selection of specific modes and the like, which are within the scope and disclosure of the present invention, are contemplated by the present invention.
Claims (10)
1. A multi-enzyme composition for endoscope cleaning, comprising a composition a and a composition B, wherein the composition a comprises: alkaline protease, lipase, amylase, cellulase, ribonuclease, polyvinyl methyl ether, diethanolamine; the composition B comprises: lysozyme, muramidase, sodium borate, diethanolamine and sodium sulfate.
2. The multi-enzyme composition according to claim 1, wherein the composition a comprises, in parts by mass: 1-20 parts of alkaline protease, 0.5-10 parts of lipase, 0.5-10 parts of amylase, 0.5-10 parts of cellulase, 0.01-0.5 part of ribonuclease, 0.1-2 parts of polyvinyl methyl ether and 0.1-2 parts of diethanolamine; the composition B comprises the following components in parts by mass: 1-5 parts of lysozyme, 1-5 parts of lywallzyme, 0.1-2 parts of sodium borate, 0.1-2 parts of diethanolamine and 0.1-2 parts of sodium sulfate.
3. The multi-enzyme composition according to claim 2, wherein the composition A comprises the following components in parts by mass: 5 parts of alkaline protease, 3 parts of lipase, 2 parts of amylase, 2 parts of cellulase, 0.05 part of ribonuclease, 0.5 part of polyvinyl methyl ether, 0.5 part of diethanolamine, and the composition B comprises the following components in parts by mass: 3 parts of lysozyme, 3 parts of lywallzyme, 0.5 part of sodium borate, 0.5 part of diethanolamine and 0.5 part of sodium sulfate.
4. The multienzyme cleaning solution for cleaning the endoscope is characterized by comprising a multienzyme cleaning solution A and a multienzyme cleaning solution B, wherein the multienzyme cleaning solution A is prepared by dissolving alkaline protease, lipase, amylase, cellulase, ribonuclease, polyvinyl methyl ether and diethanolamine in normal saline, and the pH value is adjusted to be 7-9; the multienzyme cleaning solution B is prepared by dissolving lysozyme, lywallzyme, sodium borate, diethanolamine and sodium sulfate in normal saline, and adjusting the pH value to 5-7.
5. The multienzyme cleaning solution according to claim 4, wherein the multienzyme cleaning solution A is prepared from the following components in parts by mass: 1-20% of alkaline protease, 0.5-10% of lipase, 0.5-10% of amylase, 0.5-10% of cellulase, 0.01-0.5% of ribonuclease, 0.1-2% of polyvinyl methyl ether, 0.1-2% of diethanolamine and the balance of normal saline; the multienzyme cleaning solution B is prepared from the following components in parts by mass: 1-5% of lysozyme, 1-5% of lywallzyme, 0.1-2% of sodium borate, 0.1-2% of diethanolamine, 0.1-2% of sodium sulfate and the balance of normal saline.
6. The multi-enzyme cleaning solution according to claim 5, wherein the multi-enzyme cleaning solution A is prepared from the following components in parts by mass: 5% of alkaline protease, 3% of lipase, 2% of amylase, 2% of cellulase, 0.05% of ribonuclease, 0.5% of polyvinyl methyl ether, 0.5% of diethanolamine and the balance of normal saline, and the pH value is adjusted to 7.5; the multienzyme cleaning solution B is prepared from the following components in parts by mass: 3% lysozyme, 3% lywallzyme, 0.5% sodium borate, 0.5% diethanolamine, 0.5% sodium sulfate, and the balance normal saline, and the pH value is adjusted to 6.5.
7. A preparation method of a multienzyme cleaning solution for an endoscope is characterized by comprising the following steps: respectively weighing alkaline protease, lipase, amylase, cellulase, ribonuclease, polyvinyl methyl ether and diethanolamine, dissolving in normal saline, adjusting pH to 7-9, and using as multienzyme cleaning solution A; lysozyme, lywallzyme, sodium borate, diethanolamine and sodium sulfate are respectively weighed and dissolved in normal saline, and the pH value is adjusted to 5-7 to be used as multienzyme cleaning liquid B.
8. A kit comprising a multi-enzyme composition according to any one of claims 1 to 3 or a multi-enzyme wash according to any one of claims 4 to 6.
9. Use of the multi-enzyme composition according to any one of claims 1-3 or the multi-enzyme washing solution according to any one of claims 4-6 or the kit according to claim 8 for washing a medical endoscope.
10. A multi-enzyme cleaning solution for endoscopes, characterized by being prepared by the method of claim 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210045248.4A CN115247106A (en) | 2022-01-15 | 2022-01-15 | Endoscope multienzyme cleaning composition and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210045248.4A CN115247106A (en) | 2022-01-15 | 2022-01-15 | Endoscope multienzyme cleaning composition and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115247106A true CN115247106A (en) | 2022-10-28 |
Family
ID=83698553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210045248.4A Pending CN115247106A (en) | 2022-01-15 | 2022-01-15 | Endoscope multienzyme cleaning composition and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115247106A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102919273A (en) * | 2004-09-10 | 2013-02-13 | 诺维信北美公司 | Methods for preventing, removing, reducing, or disrupting biofilm |
CN104073380A (en) * | 2013-12-05 | 2014-10-01 | 成都老肯科技股份有限公司 | Multi-enzyme cleaner suitable for endoscope cleaning and preparation method thereof |
CN105385512A (en) * | 2015-12-15 | 2016-03-09 | 山东消博士消毒科技股份有限公司 | Low-foam multienzyme cleaning fluid for medical apparatus cleaning and preparation technology thereof |
CN109486563A (en) * | 2018-10-18 | 2019-03-19 | 南京巨鲨显示科技有限公司 | A kind of scope multienzyme cleaning agent and preparation method thereof |
CN111349524A (en) * | 2018-12-21 | 2020-06-30 | 哈尔滨三联药业股份有限公司 | Multienzyme cleaning agent and preparation method and application thereof |
CN112358916A (en) * | 2020-11-20 | 2021-02-12 | 山东消博士消毒科技股份有限公司 | Multienzyme cleaning solution and preparation method thereof |
-
2022
- 2022-01-15 CN CN202210045248.4A patent/CN115247106A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102919273A (en) * | 2004-09-10 | 2013-02-13 | 诺维信北美公司 | Methods for preventing, removing, reducing, or disrupting biofilm |
CN104073380A (en) * | 2013-12-05 | 2014-10-01 | 成都老肯科技股份有限公司 | Multi-enzyme cleaner suitable for endoscope cleaning and preparation method thereof |
CN105385512A (en) * | 2015-12-15 | 2016-03-09 | 山东消博士消毒科技股份有限公司 | Low-foam multienzyme cleaning fluid for medical apparatus cleaning and preparation technology thereof |
CN109486563A (en) * | 2018-10-18 | 2019-03-19 | 南京巨鲨显示科技有限公司 | A kind of scope multienzyme cleaning agent and preparation method thereof |
CN111349524A (en) * | 2018-12-21 | 2020-06-30 | 哈尔滨三联药业股份有限公司 | Multienzyme cleaning agent and preparation method and application thereof |
CN112358916A (en) * | 2020-11-20 | 2021-02-12 | 山东消博士消毒科技股份有限公司 | Multienzyme cleaning solution and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
高向阳: "《食品酶学》", 中国轻工业出版社, pages: 117 - 119 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10264786B2 (en) | Antiseptic compositions, methods and systems | |
JP5718913B2 (en) | Catheter lock solution with antibacterial and anticoagulant properties | |
Menyhay et al. | Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic-barrier cap | |
Kaler et al. | Successful disinfection of needleless access ports: a matter of time and friction | |
US20090221989A1 (en) | System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid composition | |
CN106070291A (en) | A kind of bactericidal composition and its preparation method and application | |
CN113667193B (en) | Medical ultrasonic probe antibacterial isolation sleeve and preparation method thereof | |
CN115247106A (en) | Endoscope multienzyme cleaning composition and application thereof | |
US6858021B2 (en) | Method for decreasing catheter-associated bacteriuria | |
Carr-Locke et al. | Disinfection of upper gastrointestinal fibreoptic endoscopy equipment: an evaluation of a cetrimide chlorhexidine solution and glutaraldehyde. | |
Zhu et al. | Antimicrobial and cleaning effects of ultrasonic-mediated plasma-loaded microbubbles on Enterococcus faecalis biofilm: an in vitro study | |
Anne-Marie et al. | Biofilm on Tenckhoff catheters: a negligible source of contamination | |
de Cabo et al. | A new method of disinfection of the flexible fibrebronchoscope. | |
Mervine et al. | Using a microwave oven to disinfect intermittent-use catheters | |
Reid | Biofilms in urinary tract infections | |
Bach et al. | Catheter-related infections in long-term catheterized dogs. Observations on pathogenesis, diagnostic methods, and antibiotic lock technique | |
WO2022112591A1 (en) | A method for removing a biofilm. | |
Witchell | Management of tubes, drains and lines | |
Pulcini et al. | Biofilms and device implants | |
Olson | Validation of ATS as an appropriate test soil to assess cleaning and sterilization efficacy in |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |